Is Edgewise Therapeutics Inc (NASDAQ: EWTX) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

EWTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Edgewise Therapeutics Inc is $2.53B. A total of 0.84 million shares were traded on the day, compared to an average of 872.46K shares.

In the most recent transaction, Russell Alan J sold 8,015 shares of EWTX for 30.02 per share on Feb 05 ’25. After the transaction, the Chief Scientific Officer now owns 14,863 company shares. In a previous transaction on Feb 06 ’25, Russell Alan J sold 1,200 shares at 30.13 per share. EWTX shares that Chief Scientific Officer owns now total 14,863.

Among the insiders who sold shares, KOCH KEVIN disposed of 8,636 shares on Feb 05 ’25 at a per-share price of $30.03. This resulted in the President and CEO holding 14,478 shares of EWTX after the transaction. In another insider transaction, KOCH KEVIN sold 900 shares at $31.13 per share on Feb 06 ’25. Company shares held by the President and CEO now total 14,478.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EWTX has a high of $38.12 and a low of $14.90.

As of this writing, EWTX has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.59.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EWTX’s latest balance sheet shows that the firm has $280.79M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.52M in liabilities at the time. Its Book Value Per Share was $5.18, while its Total Shareholder’s Equity was $274.38M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EWTX is Buy with a score of 4.63.

Most Popular

Related Posts